NGHIÊN CỨU NỒNG ĐỘ HS-CRP HUYẾT TƯƠNG VÀ MỘT SỐ YẾU TỐ NGUY CƠ TIM MẠCH Ở BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TÝP 2

Đào Huỳnh Thị Anh; Quỳnh Vũ Thị Chúc

Keywords:

Cardiovascular risk factors, Type 2 diabetes

Abstract

Objectives: Survey hs-CRP plasma concentrations and some cardiovascular risk factors in type 2 diabetic patients treated at Military Hospital 175.

Methods and Subjects: A cross-sectional description study. 118 patients with type 2 diabetes were treated at Cardiovascular Department of Military Hospital 175 from April 2018 to March 2019.

Results: Men accounted for 44.9%, women 55.1%. The average age was 60,8 ± 12,12. The average duration of disease was 3.12±2.29 years. The associated cardiovascular risk factors accounted for a high proportion, including smoking (11%), low physical activity (66.1%), overweight-obesity (45.8%), and hypertension (67.8%) and dyslipidemia was the highest proportion (73.7%). The number of patients with more than 1 risk factor was common, in which the patient with 2 risk factors (29.66%), 3 risk factors was highest (36.44%) and 4 risk factors (21.18%). The average value of hs-CRP concentration is 7.66±18.98 mg/dl, and it was significantly higher than reference value with p<0.05. The group of patients with hs-CRP levels above 3mg/dl (corresponding to high cardiovascular risk) accounted for the highest proportion (36.44%).

Conclusions: Plasma hs-CRP concentration in patients with type 2 diabetes was higher than that of normal people, and patients with hs-CRP above 3 mg/dl were majority. At the same time, these patients often had many other cardiovascular risk factors.

References

Đào Thị Dừa, Trần Thừa Nguyên, Trần Huy Hoàng, cs. (2017), “Nghiên cứu mối tương quan giữa nồng độ hs-CRP huyết thanh với một số yếu tố nguy cơ tim mạch ở bệnh nhân đái tháo đường týp 2”, Chuyên đề đái tháo đường, Hội nội tiết đái tháo đường Việt Nam.

Lê Đình Tuân, Nguyễn Thị Hồ Lan, Trần Thị Thanh Hóa, cs. (2015), “Nghiên cứu nồng độ Glucagon-like peptide 1 ở bệnh nhân đái tháo đường týp 2”, Tạp chí y dược học quân sự, 9.

Trần Thanh Sang, Nguyễn Thị Bích Đào (2014), “hs-CRP và Fibrinogen ở bệnh nhân đái tháo đường týp 2 không bệnh lý tim mạch”, Tạo chí nghiên cứu y học, Y học TP Hồ Chí Minh, 18(4/2014), tr.53-59.

Trần Thị Trúc Linh (2016), “Nghiên cứu mối liên quan giữa biểu hiện tim với mục tiêu theo khuyến cáo ESC-EASD ở bệnh nhân đái tháo đường týp 2 có tăng huyết áp”, Luận án tiến sỹ y học.

Mahajan A., Jaiswal A., Tabassum R., et al. (2012), “Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians”, Atherosclerosis, 220(1), 275-81.

Pan An, Wang Yeli, Yuan Jian-Min, et al. (2017), “High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case–control study nested within the Singapore Chinese Health Study”, BMC Endocrine Disorders, 17(1), 8.

Roopakala M, Pawan H, Krishnamurthy U, et al. (2012), “Evaluation of high sensitivity creactive protein and glycated hemoglobin levels in diabetic nephropathy”, Saudi Journal of Kidney Diseases and Transplantation, 23(2), 286-289.

Schnell Oliver, Amann-Zalan Ildiko, Jelsovsky Zhihong, et al. (2013), “Changes in A1C Levels Are Significantly Associated With Changes in Levels of the Cardiovascular Risk Biomarker hs-CRP: Results from the SteP study”, Diabetes Care, 36(7), 2084-2089.

Verma Meena, Paneri Sangeeta, Badi Preetha, et al. (2006), “Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity”, Indian journal of clinical biochemistry : IJCB, 21(1), 142-146.